View this email in your browser

How does a pan-AAV assay perform outside the developer’s lab?

Join guest speakers from Multus Biotechnology and Matica Biotechnology as they share their independent evaluations of the Pan AAV Capsid Titer Assay (PACTA).

In this Spotlight Session, you’ll hear how the two organizations evaluated PACTA in their own workflows, including:

• Assay performance across multiple AAV serotypes and applications
• Reproducibility and other performance characteristics
• Automation and scaling from 96- to 384-well formats for higher-throughput workflows

We will also have a Q&A session where you can ask questions.

10 November 2026
10:00 AM ET | 3:00 PM GMT | 4:00 PM CET

Save your spot ? https://events.teams.microsoft.com/event/48d33ccb-b69c-4539-940d-4a19c6558eaf@a4744649-0f6b-4385-af2a-9ef4dc193d09

We look forward to seeing you there!